Decision letter for "Pyrazole/pyrimidine derivatives endowed with azobenzenes as dual EGFR T790M and VEGFR-2 inhibitors: Anticancer, docking, synthesis, design and ADMET assessments"
Fields of Study & Subjects
Heterocyclic Compound Synthesis and Bioactivity
Synthesis and Characterization of Heterocyclic Compounds
Computational Drug Discovery Methods
Publication details
- Journal / source
- Publons reviews and discussion
- Publication date
- 12 February 2026
- Language
- EN